Albumin for Patients With Acute Large Vessel Occlusive Stroke Undergoing Endovascular Reperfusion Therapy
A phase 2 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 134 participants.
Also called NCT06538844
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; double masking; primary purpose treatment
- Phase
- Phase 2
- Enrolled
- 134 participants
- Registry
-
NCT06538844
-
- Other papers using this trial's data
- Efficacy and safety of albumin combined with endovascular therapy in the treatment of patients with acute ischemic stroke: a randomized clinical trial
- Started
- (actual)
- Primary completion
- (actual)
- Completion
- (actual)
- Countries
- China
- Registry status
- Completed
Technical summary
Registry record NCT06538844. Randomized; double masking; primary purpose treatment. Start 2024-08-10 (actual); primary completion 2024-12-20 (actual). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Albumin for Patients With Acute Large Vessel Occlusive Stroke Undergoing Endovascular Reperfusion Therapy
- Condition
- Acute Ischemic Stroke
- Intervention (Drug)
- Intravenous infusion of human albumin
- Intervention (Drug)
- Saline
- Lead sponsor
- Capital Medical University
- Collaborator
- Xuanwu Hospital, Beijing
Record details
- Record id
cardio:ct-nct06538844- Content hash
ef9c6ae5cb6d7dfb7830889aeb63bc1d22f8791d6998edec26441e40fee77a26